Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.67
+0.15 (1.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bioventus Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bioventus stock have an average target of 15, with a low estimate of 13 and a high estimate of 17. The average target predicts an increase of 40.58% from the current stock price of 10.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioventus stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +21.84% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +40.58% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +59.33% | Sep 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +12.46% | Aug 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +12.46% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
569.91M
from 512.35M
Increased by 11.24%
Revenue Next Year
608.49M
from 569.91M
Increased by 6.77%
EPS This Year
0.41
from -2.49
EPS Next Year
0.64
from 0.41
Increased by 54.92%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 592.7M | 637.8M | 684.8M |
| Avg | 569.9M | 608.5M | 647.0M |
| Low | 552.7M | 585.1M | 616.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 15.7% | 11.9% | 12.5% |
| Avg | 11.2% | 6.8% | 6.3% |
| Low | 7.9% | 2.7% | 1.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.43 | 0.82 | 1.05 |
| Avg | 0.41 | 0.64 | 0.78 |
| Low | 0.39 | 0.47 | 0.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 99.4% | 65.0% |
| Avg | - | 54.9% | 23.0% |
| Low | - | 14.5% | -15.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.